News & Insights
President Trump Issues Executive Order to Move Cannabis to Schedule III of the Controlled Substances Act
President Trump has issued an Executive Order directing the rescheduling of cannabis to Schedule III under the Controlled Substances Act—a significant development with potential implications for cannabis operators, healthcare stakeholders, and other regulated industries.
At Feldman Legal Advisors, we break down what this executive order does (and does not) do, the legal and regulatory context, and what stakeholders should be watching as the process moves forward.
Feldman Legal Advisors Welcomes Dr. Jessica Steinberg as UK Associate
New York, NY, August 2025: Feldman Legal Advisors is delighted to announce that our law clerk, Jessica Steinberg, Ph.D., is now officially licensed to practice law in England and Wales, and has elevated her position with the firm to Associate based in London. Dr. Steinberg will continue working on behalf of clients across our cannabis, psychedelics, and corporate transactional legal practice.
June 2025 Newsletter
As the summer unfolds, we’re taking a moment to reflect with gratitude and excitement on the progress we’ve made, both personally and professionally. The movement for psychedelics and cannabis law reform continues to gain momentum, and we’re honored to be part of it alongside so many inspiring clients, collaborators, and advocates.